Bridging dose of U-100 glargine with first dose of insulin degludec improves glycaemia in the 48 h after transition in twice-daily glargine users.

Thirumalai, Arthi; Chao, Jing H; Kaleru, Thanmai; Dong, Xiaofu; Mandava, Patali; Khakpour, Dori; Hirsch, Irl B

Thirumalai, Arthi; Chao, Jing H; Kaleru, Thanmai; Dong, Xiaofu; Mandava, Patali; Khakpour, Dori; Hirsch, Irl B.

Afiliação

Thirumalai A; Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington, USA.
Chao JH; Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington, USA.
Kaleru T; Internal Medicine Residency, Trios Health, Kennewick, Washington, USA.
Dong X; University of Washington Medicine Diabetes Institute, Seattle, Washington, USA.
Mandava P; University of Washington Medicine Diabetes Institute, Seattle, Washington, USA.
Khakpour D; University of Washington Medicine Diabetes Institute, Seattle, Washington, USA.
Hirsch IB; Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington, USA.

Diabetes Obes Metab ; 26(5): 1868-1876, 2024 May.

Article em En | MEDLINE | ID: mdl-38418413

Assuntos

Diabetes Mellitus Tipo 1; Insulina de Ação Prolongada; Humanos; Masculino; Pessoa de Meia-Idade; Feminino; Insulina Glargina/efeitos adversos; Diabetes Mellitus Tipo 1/tratamento farmacológico; Hipoglicemiantes/efeitos adversos; Projetos Piloto; Glicemia

Palavras-chave

basal insulin; continuous glucose monitoring (CGM); glycaemic control; type 1 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insulina de Ação Prolongada / Diabetes Mellitus Tipo 1 Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google